🕷️ Crawler Inspector

 [Skip to main content](https://www.theguardian.com/society/2021/jun/02/who-approves-chinas-sinovac-covid-vaccine#maincontent)[Skip to navigation](https://www.theguardian.com/society/2021/jun/02/who-approves-chinas-sinovac-covid-vaccine#navigation) Close dialogue 1/1 Next image Previous image Toggle caption [Skip to navigation](https://www.theguardian.com/society/2021/jun/02/who-approves-chinas-sinovac-covid-vaccine#navigation) [Print subscriptions](https://support.theguardian.com/subscribe/weekly?REFPVID=mmxgwfmmxz247xu4rbcg&INTCMP=undefined&acquisitionData=%7B%22source%22%3A%22GUARDIAN_WEB%22%2C%22componentId%22%3A%22PrintSubscriptionsHeaderLink%22%2C%22componentType%22%3A%22ACQUISITIONS_HEADER%22%2C%22referrerPageviewId%22%3A%22mmxgwfmmxz247xu4rbcg%22%2C%22referrerUrl%22%3A%22https%3A%2F%2Fwww.theguardian.com%2Fsociety%2F2021%2Fjun%2F02%2Fwho-approves-chinas-sinovac-covid-vaccine%22%7D) [Search jobs](https://jobs.theguardian.com/) [Sign in](https://profile.theguardian.com/signin?INTCMP=DOTCOM_NEWHEADER_SIGNIN&ABCMP=ab-sign-in&componentEventParams=componentType%3Didentityauthentication%26componentId%3Dguardian_signin_header) Eur - [Europe edition](https://www.theguardian.com/preference/edition/eur) - [UK edition](https://www.theguardian.com/preference/edition/uk) - [US edition](https://www.theguardian.com/preference/edition/us) - [Australia edition](https://www.theguardian.com/preference/edition/au) - [International edition](https://www.theguardian.com/preference/edition/int) [The Guardian - Back to homeThe Guardian](https://www.theguardian.com/) - [News](https://www.theguardian.com/) - [Opinion](https://www.theguardian.com/commentisfree) - [Sport](https://www.theguardian.com/sport) - [Culture](https://www.theguardian.com/culture) - [Lifestyle](https://www.theguardian.com/lifeandstyle) Show more Hide expanded menu - News - [View all News](https://www.theguardian.com/) - [World news](https://www.theguardian.com/world) - [UK news](https://www.theguardian.com/uk-news) - [Climate crisis](https://www.theguardian.com/environment/climate-crisis) - [Ukraine](https://www.theguardian.com/world/ukraine) - [Environment](https://www.theguardian.com/environment) - [Science](https://www.theguardian.com/science) - [Global development](https://www.theguardian.com/global-development) - [Football](https://www.theguardian.com/football) - [Tech](https://www.theguardian.com/technology) - [Business](https://www.theguardian.com/business) - [Obituaries](https://www.theguardian.com/obituaries) - Opinion - [View all Opinion](https://www.theguardian.com/commentisfree) - [The Guardian view](https://www.theguardian.com/profile/editorial) - [Columnists](https://www.theguardian.com/index/contributors) - [Cartoons](https://www.theguardian.com/tone/cartoons) - [Opinion videos](https://www.theguardian.com/type/video+tone/comment) - [Letters](https://www.theguardian.com/tone/letters) - Sport - [View all Sport](https://www.theguardian.com/sport) - [Football](https://www.theguardian.com/football) - [Cricket](https://www.theguardian.com/sport/cricket) - [Rugby union](https://www.theguardian.com/sport/rugby-union) - [Tennis](https://www.theguardian.com/sport/tennis) - [Cycling](https://www.theguardian.com/sport/cycling) - [F1](https://www.theguardian.com/sport/formulaone) - [Golf](https://www.theguardian.com/sport/golf) - [US sports](https://www.theguardian.com/sport/us-sport) - Culture - [View all Culture](https://www.theguardian.com/culture) - [Books](https://www.theguardian.com/books) - [Music](https://www.theguardian.com/music) - [TV & radio](https://www.theguardian.com/tv-and-radio) - [Art & design](https://www.theguardian.com/artanddesign) - [Film](https://www.theguardian.com/film) - [Games](https://www.theguardian.com/games) - [Classical](https://www.theguardian.com/music/classicalmusicandopera) - [Stage](https://www.theguardian.com/stage) - Lifestyle - [View all Lifestyle](https://www.theguardian.com/lifeandstyle) - [Fashion](https://www.theguardian.com/fashion) - [Food](https://www.theguardian.com/food) - [Recipes](https://www.theguardian.com/tone/recipes) - [Love & sex](https://www.theguardian.com/lifeandstyle/love-and-sex) - [Health & fitness](https://www.theguardian.com/lifeandstyle/health-and-wellbeing) - [Home & garden](https://www.theguardian.com/lifeandstyle/home-and-garden) - [Women](https://www.theguardian.com/lifeandstyle/women) - [Men](https://www.theguardian.com/lifeandstyle/men) - [Family](https://www.theguardian.com/lifeandstyle/family) - [Travel](https://www.theguardian.com/travel) - [Money](https://www.theguardian.com/money) - [Support us](https://support.theguardian.com/?INTCMP=side_menu_support&acquisitionData=%7B%22source%22:%22GUARDIAN_WEB%22,%22componentType%22:%22ACQUISITIONS_HEADER%22,%22componentId%22:%22side_menu_support%22%7D) - [Print subscriptions](https://support.theguardian.com/subscribe/weekly?REFPVID=mmxgwfmmxz247xu4rbcg&INTCMP=undefined&acquisitionData=%7B%22source%22%3A%22GUARDIAN_WEB%22%2C%22componentId%22%3A%22PrintSubscriptionsHeaderLink%22%2C%22componentType%22%3A%22ACQUISITIONS_HEADER%22%2C%22referrerPageviewId%22%3A%22mmxgwfmmxz247xu4rbcg%22%2C%22referrerUrl%22%3A%22https%3A%2F%2Fwww.theguardian.com%2Fsociety%2F2021%2Fjun%2F02%2Fwho-approves-chinas-sinovac-covid-vaccine%22%7D) - - [Search jobs](https://jobs.theguardian.com/) - [Holidays](https://holidays.theguardian.com/?INTCMP=holidays_int_web_newheader) - [Digital Archive](https://theguardian.newspapers.com/) - [Guardian Licensing](https://licensing.theguardian.com/) - [Live events](https://www.theguardian.com/guardian-live-events?INTCMP=live_eur_header_dropdown) - [About Us](https://www.theguardian.com/about) - [The Guardian app](https://app.adjust.com/16xt6hai) - [Video](https://www.theguardian.com/video) - [Podcasts](https://www.theguardian.com/podcasts) - [Pictures](https://www.theguardian.com/inpictures) - [Newsletters](https://www.theguardian.com/email-newsletters) - [Today's paper](https://www.theguardian.com/theguardian) - [Inside the Guardian](https://www.theguardian.com/insidetheguardian) - [Guardian Weekly](https://www.theguardian.com/weekly?INTCMP=gdnwb_mawns_editorial_gweekly_GW_TopNav_Int) - [Crosswords](https://www.theguardian.com/crosswords) - [Wordiply](https://www.wordiply.com/) - [Corrections](https://www.theguardian.com/theguardian/series/corrections-and-clarifications) - [Tips](https://www.theguardian.com/tips) - - [Search jobs](https://jobs.theguardian.com/) - [Holidays](https://holidays.theguardian.com/?INTCMP=holidays_int_web_newheader) - [Digital Archive](https://theguardian.newspapers.com/) - [Guardian Licensing](https://licensing.theguardian.com/) - [Live events](https://www.theguardian.com/guardian-live-events?INTCMP=live_eur_header_dropdown) - [About Us](https://www.theguardian.com/about) - [UK](https://www.theguardian.com/uk-news) - [UK politics](https://www.theguardian.com/politics) - [Education](https://www.theguardian.com/education) - [Media](https://www.theguardian.com/media) - [Society](https://www.theguardian.com/society) - [Law](https://www.theguardian.com/law) - [Scotland](https://www.theguardian.com/uk/scotland) - [Wales](https://www.theguardian.com/uk/wales) - [Northern Ireland](https://www.theguardian.com/uk/northernireland)  A healthcare worker administers a dose of Sinovac’s CoronaVac vaccine to a woman in the Philippines. Photograph: Ezra Acayan/Getty Images [View image in fullscreen](https://www.theguardian.com/society/2021/jun/02/who-approves-chinas-sinovac-covid-vaccine#img-1) A healthcare worker administers a dose of Sinovac’s CoronaVac vaccine to a woman in the Philippines. Photograph: Ezra Acayan/Getty Images [Vaccines and immunisation](https://www.theguardian.com/society/vaccines) This article is more than **4 years old** # WHO approves China’s Sinovac Covid vaccine This article is more than 4 years old Emergency use listing gives countries, funders, procuring agencies and communities assurance it has met international standards - [See all our coronavirus coverage](https://www.theguardian.com/world/coronavirus-outbreak) Agence France-Presse Wed 2 Jun 2021 02.01 CEST Share [Prefer the Guardian on Google](https://www.google.com/preferences/source?q=theguardian.com) The World Health Organization has approved the Sinovac Covid-19 vaccine for emergency use – the second Chinese vaccine to receive the WHO’s green light. The UN health agency signed off on CoronaVac, a two-dose vaccine developed by the Beijing-based firm which is already being deployed in several countries around the world. “I’m happy to announce that the Sinovac-CoronaVac vaccine has been given WHO emergency use listing after being found to be safe, effective, and quality-assured,” WHO chief Tedros Adhanom Ghebreyesus told a press conference on Tuesday. [China locks down part of Guangzhou amid outbreak of Indian Covid variant Read more](https://www.theguardian.com/world/2021/jun/01/china-locks-down-part-of-guangzhou-amid-outbreak-of-indian-covid-variant) “The easy storage requirements of CoronaVac make it very suitable for low-resource settings,” he added. “It’s now crucial to get these life-saving tools to the people that need them quickly.” The WHO said the emergency use listing (EUL) gives countries, funders, procuring agencies and communities assurance that the vaccine has met international standards. Last month [Sinopharm became the first Chinese vaccine](https://www.theguardian.com/world/2020/dec/14/chinas-sinopharm-vaccine-how-effective-is-it-and-where-will-it-be-rolled-out) to be approved by the WHO. The organisation has also given EUL status to vaccines being made by Pfizer/BioNTech, Moderna, Johnson & Johnson, and the AstraZeneca jab being produced in India, South Korea and the EU, which it counts separately. WHO’s listing paves the way for countries worldwide to approve and import a vaccine for distribution quickly, especially those states without an international-standard regulator of their own. [China forces pace of vaccinations with persuasion … and some cash Read more](https://www.theguardian.com/world/2021/may/30/china-forces-pace-of-vaccinations-with-persuasion-and-some-cash) It also opens the door for the jabs to enter the Covax global vaccine-sharing facility, which aims to provide equitable access to doses around the world, particularly in poorer countries. Currently only AstraZeneca and some Pfizer jabs are flowing through the scheme. “The world desperately needs multiple Covid-19 vaccines to address the huge access inequity across the globe,” said Mariangela Simao, the WHO’s assistant director general for access to health products. “We urge manufacturers to participate in the Covax facility, share their knowhow and data and contribute to bringing the pandemic under control.” “WHO recommends the vaccine for use in adults 18 years and older, in a two-dose schedule with a spacing of two to four weeks,” the agency said in a statement. “Vaccine efficacy results showed that the vaccine prevented symptomatic disease in 51 percent of those vaccinated and prevented severe Covid-19 and hospitalisation in 100 percent of the studied population.” The Sinovac vaccine contains an inactivated form of coronavirus that cannot cause the disease. It also has a substance that helps strengthen the immune response to the vaccine. When given the shot, the immune system identifies the inactivated virus as foreign and makes antibodies against it, which will then recognise the active virus and defend the body against it. Few people aged over 60 took part in the clinical trial of Sinovac’s jab. However, the WHO said there should be no upper age limit on the vaccine as there is “no reason to believe it has a different safety profile” in older generations. The Sinovac jab is already in use in 22 territories around the world, according to an AFP count. Apart from [China](https://www.theguardian.com/world/china), the countries using Sinovac include Chile, Brazil, Indonesia, Mexico, Thailand and Turkey. Chen Xu, China’s ambassador in Geneva, said CoronaVac’s EUL status expanded the number of global tools to fight the pandemic. “China will continue to work with the international community to promote the accessibility and affordability of Covid-19 vaccines especially in (the) developing world,” he said in a tweet. Explore more on these topics - [Vaccines and immunisation](https://www.theguardian.com/society/vaccines) - [China](https://www.theguardian.com/world/china) - [Coronavirus](https://www.theguardian.com/world/coronavirus-outbreak) - [Asia Pacific](https://www.theguardian.com/world/asia-pacific) - [news](https://www.theguardian.com/tone/news) Share [Reuse this content](https://syndication.theguardian.com/?url=https%3A%2F%2Fwww.theguardian.com%2Fsociety%2F2021%2Fjun%2F02%2Fwho-approves-chinas-sinovac-covid-vaccine&type=article&internalpagecode=society/2021/jun/02/who-approves-chinas-sinovac-covid-vaccine "Reuse this content") ### Most viewed - [ LiveMiddle East crisis live: Hegseth addresses media after Trump threatens to ‘blow up’ entire South Pars gasfield](https://www.theguardian.com/world/live/2026/mar/19/iran-war-live-updates-oil-prices-gas-field-strikes-pentagon-more-funds-trump-news) - [ The WNBA’s new labor deal explained: what it means for pay, power and the league’s future](https://www.theguardian.com/sport/2026/mar/18/wnba-cba-explained-salaries-revenue-player-pay-deal) - [ Dear allies of America, please don’t confuse our president for usRobert Reich](https://www.theguardian.com/commentisfree/2026/mar/19/donald-trump-american-ally) - [ Analysis from West Point warns that strait of Hormuz blockade will strangle US defense industry](https://www.theguardian.com/world/2026/mar/19/west-point-analysis-iran-war-costs) - [ ‘Damage will be widespread’: Tropical Cyclone Narelle brings 315km/h wind gusts, with tourists evacuated and schools closed](https://www.theguardian.com/australia-news/2026/mar/19/tropical-cyclone-narelle-qld-storm-tracker-path-tracking-map-bom) ## Related stories ## Related stories -  ### Vaccines are key to China’s zero-Covid exit but scepticism poses challenge 2 Dec 2022 -  ### Hong Kong authorises Sinovac Covid vaccine for children aged 3 to 17 20 Nov 2021 -  ### Xi Jinping calls for mutual Covid vaccine approvals 30 Oct 2021 -  ### Taiwan tech companies buy 10m Covid vaccine doses in deal that sidesteps China 12 Jul 2021 -  ### ‘Forces for good will prevail’: Joy in Taiwan as US sends 2.5m Covid vaccine doses 20 Jun 2021 -  ### ‘Urgent need’: US to donate 750,000 Covid vaccine doses to Taiwan 6 Jun 2021 -  ### Taiwan accuses China of interfering with Covid vaccine deals 27 May 2021 -  ### India approves Oxford/AstraZeneca Covid vaccine 2 Jan 2021 ## More from News ## More from News -  ### Europe liveHungary’s Orbán says he won’t back down and allow EU’s €90bn loan to Ukraine 15m ago -  ### RussiaRussian oil tanker heading to Cuba amid US economic blockade 11h ago -  ### IrelandLeo Varadkar: LGBTQ+ rights in Europe face ‘chill wind’ from east and west 6h ago -  ### UK‘Superhuman’ healthcare workers saved NHS from collapse, Covid inquiry finds 48m ago -  ### UK politicsFarage called Welsh people ‘foreign speakers’ in paid-for video message 49m ago -  ### World Cup 2026Iran will boycott the US but not the World Cup, country’s football head says 3h ago -  ### IrelandSt Patrick’s Day float referencing Epstein files draws condemnation in Ireland 23m ago -  ### FootballUefa plans to offer Champions League streaming service direct to fans 23m ago -  ### AustraliaLive possum appears among plush toy animals in airport gift shop 8h ago ## Most viewed ## Most viewed - [Most viewed Across the Guardian](https://www.theguardian.com/society/2021/jun/02/tabs-popular-0) - [Most viewed in Society](https://www.theguardian.com/society/2021/jun/02/tabs-popular-1) ### Most viewed Across the\ Guardian 1. [LiveMiddle East crisis live: Hegseth addresses media after Trump threatens to ‘blow up’ entire South Pars gasfield](https://www.theguardian.com/world/live/2026/mar/19/iran-war-live-updates-oil-prices-gas-field-strikes-pentagon-more-funds-trump-news) 2. [FBI investigating US counter-terrorism chief who resigned over Iran war, reports say](https://www.theguardian.com/us-news/2026/mar/19/fbi-probing-counterterrorism-official-who-resigned-over-iran-war-reports-say) 3. [The war on Iran cost the US \$12.7bn by day six. Here’s how it’s been spent – in charts](https://www.theguardian.com/world/ng-interactive/2026/mar/19/us-iran-war-cost) 4. [Trump threatens to ‘blow up’ all of Iran’s South Pars gasfield if Tehran strikes Qatar](https://www.theguardian.com/world/2026/mar/19/iran-war-trump-south-pars-threat-if-tehran-strikes-qatar) 5. [Possum found nestled in with plush toys at airport gift shop in Tasmania](https://www.theguardian.com/australia-news/2026/mar/19/possum-hobart-airport-gift-shop-soft-toys) 6. [LiveHungary’s Orbán says he won’t back down and allow EU’s €90bn loan to Ukraine – Europe live](https://www.theguardian.com/world/live/2026/mar/19/europe-ukraine-russian-eu-loan-orban-hungary-tariffs-iran-nato-latest-news-updates) 7. [Democrats walk out in protest over ‘outrageous fake’ Epstein briefing from Pam Bondi](https://www.theguardian.com/us-news/2026/mar/18/pam-bondi-epstein-briefing-democrats) 8. [Middle East war: why attacks on gasfields like South Pars are a major escalation](https://www.theguardian.com/world/2026/mar/18/middle-east-war-why-attacks-gasfield-south-pars-are-a-major-escalation) 9. [Homework till midnight and ‘one breakdown a week’: the mysterious art school keeping a forgotten style alive](https://www.theguardian.com/artanddesign/2026/mar/19/van-der-kelen-painting-school-brussels-art) 10. [Russian oil tanker heading to Cuba amid US economic blockade](https://www.theguardian.com/world/2026/mar/19/cuba-us-economic-blockade-trump-russian-oil-tanker) ### Most viewed in Society 1. [Number of meningitis cases linked to Kent outbreak rises to 27](https://www.theguardian.com/society/2026/mar/19/number-meningitis-cases-linked-kent-outbreak-rises) 2. [Ministers announce huge expansion of electronic tagging in England and Wales](https://www.theguardian.com/society/2026/mar/19/electronic-tagging-offenders-england-and-wales-expansion) 3. [‘Superhuman’ healthcare workers saved NHS from collapse, Covid inquiry finds](https://www.theguardian.com/society/2026/mar/19/superhuman-healthcare-workers-saved-nhs-from-collapse-covid-inquiry-concludes) 4. [‘They were comparing me to Bonnie Blue’: the disturbing rise of nightlife content](https://www.theguardian.com/society/2026/mar/18/disturbing-rise-of-nightlife-content-bonnie-blue) 5. [Kent meningitis outbreak has been contained, health officials believe](https://www.theguardian.com/society/2026/mar/18/kent-meningitis-outbreak-has-been-contained-health-officials-believe) 6. [Watchdog takes over running of home for adults with learning disabilities](https://www.theguardian.com/society/2026/mar/19/charity-commission-william-blake-house-northamptonshire-adults-learning-disabilities-investigation) 7. [What is behind the UK’s meningitis outbreak and how serious is it?](https://www.theguardian.com/society/2026/mar/18/what-caused-uk-meningitis-outbreak-how-serious-is-it) 8. [Meningitis B: what are the symptoms, how is it spread and is there a vaccine?](https://www.theguardian.com/society/2026/mar/17/meningitis-b-kent-symptoms-how-is-it-spread-is-there-a-vaccine) 9. [Women and girls bearing brunt of water shortages globally, UN warns](https://www.theguardian.com/society/2026/mar/19/women-and-girls-bearing-brunt-of-water-shortages-globally-un-warns) 10. [What everyone gets wrong about the science of lip-reading](https://www.theguardian.com/society/2026/mar/18/what-everyone-gets-wrong-about-the-science-of-lip-reading) - [UK](https://www.theguardian.com/uk-news) - [UK politics](https://www.theguardian.com/politics) - [Education](https://www.theguardian.com/education) - [Media](https://www.theguardian.com/media) - [Society](https://www.theguardian.com/society) - [Law](https://www.theguardian.com/law) - [Scotland](https://www.theguardian.com/uk/scotland) - [Wales](https://www.theguardian.com/uk/wales) - [Northern Ireland](https://www.theguardian.com/uk/northernireland) - [News](https://www.theguardian.com/) - [Opinion](https://www.theguardian.com/commentisfree) - [Sport](https://www.theguardian.com/sport) - [Culture](https://www.theguardian.com/culture) - [Lifestyle](https://www.theguardian.com/lifeandstyle) Original reporting and incisive analysis, direct from the Guardian every morning [Sign up for our email](https://www.theguardian.com/global/2022/sep/20/sign-up-for-the-first-edition-newsletter-our-free-news-email) - [About us](https://www.theguardian.com/about) - [Help](https://manage.theguardian.com/help-centre) - [Complaints & corrections](https://www.theguardian.com/info/complaints-and-corrections) - [Contact us](https://www.theguardian.com/help/contact-us) - [Tip us off](https://www.theguardian.com/tips) - [SecureDrop](https://www.theguardian.com/securedrop) - [Privacy policy](https://www.theguardian.com/info/privacy) - [Cookie policy](https://www.theguardian.com/info/cookies) - [Tax strategy](https://uploads.guim.co.uk/2025/09/05/Tax_strategy_for_the_year_ended_31_March_2025.pdf) - [Terms & conditions](https://www.theguardian.com/help/terms-of-service) - [All topics](https://www.theguardian.com/index/subjects/a) - [All writers](https://www.theguardian.com/index/contributors) - [Newsletters](https://www.theguardian.com/email-newsletters?INTCMP=DOTCOM_FOOTER_NEWSLETTER_EUROPE) - [Digital newspaper archive](https://theguardian.newspapers.com/) - [Bluesky](https://bsky.app/profile/theguardian.com) - [Facebook](https://www.facebook.com/theguardian) - [Instagram](https://www.instagram.com/guardian) - [LinkedIn](https://www.linkedin.com/company/theguardian) - [Threads](https://www.threads.com/@guardian) - [TikTok](https://www.tiktok.com/@guardian) - [YouTube](https://www.youtube.com/user/TheGuardian) - [Advertise with us](https://advertising.theguardian.com/) - [Search UK jobs](https://jobs.theguardian.com/) - [Tips](https://www.theguardian.com/tips) - [Accessibility settings](https://www.theguardian.com/help/accessibility-help) - [Work with us](https://workwithus.theguardian.com/) Support the Guardian Available for everyone, funded by readers [Support us](https://support.theguardian.com/?INTCMP=footer_support&acquisitionData=%7B%22source%22:%22GUARDIAN_WEB%22,%22componentType%22:%22ACQUISITIONS_FOOTER%22,%22componentId%22:%22footer_support%22%7D) [Back to top](https://www.theguardian.com/society/2021/jun/02/who-approves-chinas-sinovac-covid-vaccine#top) © 2026 Guardian News & Media Limited or its affiliated companies. All rights reserved. (dcr)

The World Health Organization has approved the Sinovac Covid-19 vaccine for emergency use – the second Chinese vaccine to receive the WHO’s green light. The UN health agency signed off on CoronaVac, a two-dose vaccine developed by the Beijing-based firm which is already being deployed in several countries around the world. “I’m happy to announce that the Sinovac-CoronaVac vaccine has been given WHO emergency use listing after being found to be safe, effective, and quality-assured,” WHO chief Tedros Adhanom Ghebreyesus told a press conference on Tuesday. “The easy storage requirements of CoronaVac make it very suitable for low-resource settings,” he added. “It’s now crucial to get these life-saving tools to the people that need them quickly.” The WHO said the emergency use listing (EUL) gives countries, funders, procuring agencies and communities assurance that the vaccine has met international standards. Last month [Sinopharm became the first Chinese vaccine](https://www.theguardian.com/world/2020/dec/14/chinas-sinopharm-vaccine-how-effective-is-it-and-where-will-it-be-rolled-out) to be approved by the WHO. The organisation has also given EUL status to vaccines being made by Pfizer/BioNTech, Moderna, Johnson & Johnson, and the AstraZeneca jab being produced in India, South Korea and the EU, which it counts separately. WHO’s listing paves the way for countries worldwide to approve and import a vaccine for distribution quickly, especially those states without an international-standard regulator of their own. It also opens the door for the jabs to enter the Covax global vaccine-sharing facility, which aims to provide equitable access to doses around the world, particularly in poorer countries. Currently only AstraZeneca and some Pfizer jabs are flowing through the scheme. “The world desperately needs multiple Covid-19 vaccines to address the huge access inequity across the globe,” said Mariangela Simao, the WHO’s assistant director general for access to health products. “We urge manufacturers to participate in the Covax facility, share their knowhow and data and contribute to bringing the pandemic under control.” “WHO recommends the vaccine for use in adults 18 years and older, in a two-dose schedule with a spacing of two to four weeks,” the agency said in a statement. “Vaccine efficacy results showed that the vaccine prevented symptomatic disease in 51 percent of those vaccinated and prevented severe Covid-19 and hospitalisation in 100 percent of the studied population.” The Sinovac vaccine contains an inactivated form of coronavirus that cannot cause the disease. It also has a substance that helps strengthen the immune response to the vaccine. When given the shot, the immune system identifies the inactivated virus as foreign and makes antibodies against it, which will then recognise the active virus and defend the body against it. Few people aged over 60 took part in the clinical trial of Sinovac’s jab. However, the WHO said there should be no upper age limit on the vaccine as there is “no reason to believe it has a different safety profile” in older generations. The Sinovac jab is already in use in 22 territories around the world, according to an AFP count. Apart from [China](https://www.theguardian.com/world/china), the countries using Sinovac include Chile, Brazil, Indonesia, Mexico, Thailand and Turkey. Chen Xu, China’s ambassador in Geneva, said CoronaVac’s EUL status expanded the number of global tools to fight the pandemic. “China will continue to work with the international community to promote the accessibility and affordability of Covid-19 vaccines especially in (the) developing world,” he said in a tweet.